Nicardipine, a dihydropyridine type calcium channel blocker, was infused into 4-, 6-, and 23-wk-old spontaneously hypertensive (SH) and age-matched normotensive Wistar-Kyoto (WKY) rats (under sodium thiobutabarbital anesthesia and ventilation, n = 4) through the left femoral vein, resulting in the reduction of blood pressure. In each rat, mean arterial blood pressure, heart rate, and the concentration of plasma catecholamines (CAs), norepinephrine (NE), and epinephrine (E) were concomitantly determined, and the correlations between these three variables were studied. During the infusion of nicardipine, the plasma concentration of CAs was measured with an automatic detection system in blood samples collected from the right femoral artery of each rat. The reduction in blood pressure induced by nicardipine brought about an increase in plasma CA levels. The blood pressure correlated well with the logarithm of plasma NE or E concentration according to the formula Y= --a log (X) + m (Y, blood pressure; X, concentration of plasma NE or E; a, slope; and m, intercept). The slopes (as) of 6-wk-old and 23-wk-old SH rats were significantly greater than those of aged-matched WKY rats, meaning that the increment in plasma CAs in response to a decrease in blood pressure was smaller in SH than in WKY rats of similar ages. However, no significant differences were found between the as of 4-wk-old SH and WKY rats. We conclude that the increment in the baroreflex-mediated sympathetic activity in response to a drop in blood pressure induced by nicardipine is similar or greater in prehypertensive SH than in normotensive WKY 4-wk-old rats, while the increment becomes smaller in SH rats with the onset of hypertension (6-wk-old rats), and is much less in fully hypertensive adult (23-wk-old) SH rats than in age-matched WKY rats. On the basis of these findings and previous data obtained by neurogra- Many papers have reported that plasma catecholamines (CAs) can be used to evaluate baroreflexmediated sympathetic activity, because circulating CAs consist mainly of CAs liberated from the synapses of sympathetic nerves in proportion to the degree of such activity (1-10). We showed for the first time that the blood pressure reduction caused by the continuous infusion of diltiazem, verapamil, or nicardipine in Sprague-Dawley (SD) rats correlated significantly with the increases in plasma norepinephrine (NE) and epinephrine (E) concentrations (11, 12). Further studies of diltiazem and nicardipine given by infusion to adult (23 to 28 wk old) spontaneously hypertensive (SH) and agematched normotensive Wistar-Kyoto (WKY) rats revealed similar, close correlations in both strains (13). These findings showed the great contribution of baroreflex-mediated sympathetic activity to blood pressure regulation in SD, SH, and WKY rats, acting to raise the artificially diminished blood pressure to normal values. These results also revealed reduced sensitivity of the baroreflex-mediated sympathetic response in adult SH rats as compared with age-matched normotensive WKY rats once the chronic phase of hypertension is established (13). These data were obtained with the use of a fully-automated, highly-sensitive, selective system for the determination of plasma CAs, which requires only 25 pl of rat plasma (14, 15). Since the role of baroreflex-mediated sympathetic
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Many papers have reported that plasma catecholamines (CAs) can be used to evaluate baroreflexmediated sympathetic activity, because circulating CAs consist mainly of CAs liberated from the synapses of sympathetic nerves in proportion to the degree of such activity (1-10). We showed for the first time that the blood pressure reduction caused by the continuous infusion of diltiazem, verapamil, or nicardipine in Sprague-Dawley (SD) rats correlated significantly with the increases in plasma norepinephrine (NE) and epinephrine (E) concentrations (11, 12) . Further studies of diltiazem and nicardipine given by infusion to adult (23 to 28 wk old) spontaneously hypertensive (SH) and agematched normotensive Wistar-Kyoto (WKY) rats revealed similar, close correlations in both strains (13). These findings showed the great contribution of baroreflex-mediated sympathetic activity to blood pressure regulation in SD, SH, and WKY rats, acting to raise the artificially diminished blood pressure to normal values. These results also revealed reduced sensitivity of the baroreflex-mediated sympathetic response in adult SH rats as compared with age-matched normotensive WKY rats once the chronic phase of hypertension is established (13). These data were obtained with the use of a fully-automated, highly-sensitive, selective system for the determination of plasma CAs, which requires only 25 pl of rat plasma (14, 15 [2-(3,6,9-trioxadecanyloxycarbonyl)-4-nitrophenyl] oxalate (TDPO), and thiobutabarbital sodium salt were also from WAKO. Sodium octanesulfonate and imidazole (zone-refined) were obtained from Tokyo Kasei (Tokyo, Japan). Heparin sodium salt was obtained from Nacalai Tesque Inc. (Kyoto, Japan). Nicardipine hydrochloride, a dihydropyridine type calcium antagonist, was kindly donated by Yamanouchi Seiyaku, Co., Ltd. (Ibaraki, Japan). Male WKY and SH rats were supplied by Charles River Japan (Shizuoka, Japan). The ages of the rats were 4, 6, and 23 wk. Commercially available NMcDA was purified as described previously (13).
Infusion o f Nicardipine and Sample Collection and Preparation WKY and SH rats were anesthetized with sodium thiobutabarbital (100 mg/kg, intraperitoneally). Additional doses of the anesthetic (20 mg/kg) were injected after the operation and before the infusion of nicardipine. Rats were ventilated (60 strokes/min, 1 ml/100 g/stroke) until the end of the experiment, using a Model SAR-830 ventilator (CWE Co., PA, USA). Nicardipine was dissolved in saline at a concentration of 3.27 X 10-2 mg/kg/ml. The solution of nicardipine was infused into the rats through the left femoral vein with a Model CFV-3100 infusion pump (Nihon Kohden, Tokyo, Japan) at flow rates ( volume load/min) of 5.1, 10.3, 20.6, and 51.0 ,rd/min. In terms of nicardipine, these flow rates corresponded to infusion rates of 0.16, 0.33, 0.67, and 1.67 ag/kglmin. Infusion was started 30 min after surgery. The duration of each infusion was 20 min. Syringes containing the nicardipine solution were covered with aluminium foil during the infusion to prevent decomposition of nicardipine by light. Nicardipine was infused into 4 WKY and 4 SH rats of each age studied (4, 6, and 23 wk). As control, 4 WKY and 4 SH rats of each age were given saline infusions at the same flow rates as nicardipine. Arterial blood pressure and heart rate were measured through the left femoral artery with a Model DTX disposable transducer (Spectramed Inc., Oxnard, CA, USA), which was connected to a Model AP-621 G carrier amplifier for arterial blood pressure (Nihon Kohden) and a Model AT-601 G heart rate counter (Nihon Kohden), these variables were recorded on a Model WR-3701 recticorder (Graphtec, Tokyo, Japan).
Blood (0.20 ml) was collected through a catheter implanted into the right femoral artery, 10 and 5 min before the infusion of nicardipine or saline, and 15 min after the beginning of each step of the infusion. Plasma was diluted with an equivalent volume of a sample dilution buffer, the composition of which was 10 mM glutathione, 10 mM citric acid, 0.1% Triton X-100, 100 mg/l EDTA, and 8 mM NMcDA (pH 4.5). Fifty-microliter aliquots of the diluted mixture were then subjected to a fully-automated HPLC analyzer for CAs with PO-CL detection (14).
HPLC Detection System and HPLC Conditions
The fully-automated system consisted of four HPLC pumps, an autosampler, a rotatory six-way valve, a ternary gradient unit, a precolumn and an analytical column, two rotatory mixing devices, a reaction coil in a thermostatically controlled bath, and a system controller, as described previously (15). The CA extraction and HPLC conditions were as follows: precolumn, SERUMOUT-CEX, 10 X 4 mm id. (Sekisui Co., Osaka, Japan); buffer for delivering CAs in the precolumn, 10 mM potassium phosphate buffer (pH 7.5)/ethanol (92 : 8, v/v), flow rate 1.0 ml/min; adsorption time in the precolumn, 2 min; eluent, 75 mM potassium acetate buffer (pH 3. 
Method o f Statistical Analysis
Means and standard errors of arterial blood pressure, heart rate, and plasma CA concentration and correlations between these variables were calculated with Student's t-test, as described previously (12, 13).
Results
Heart rate was not significantly altered during nicardipine infusion in SH rats (SH4k, Wfrom 438 ± 28 to 423 ± 24 beats/min; SH6wk, from 442 ± 27 to 432 ± 23 beats/mm; SH23Wk, from 462 ± 25 to 451 ± 19 The continuous infusion of nicardipine resulted in a gradual decrease in mean arterial blood pressure in both SH rats (SH4k, Wfrom 116 ± 3.8 to 49 ± 3.6 mmHg; SH6wk, from 153 ± 6.5 to 60 ± 3.2 mmHg; SH23wk, from 192 ± 5.0 to 78 ± 4.2 mmHg) and WKY rats (WKY4k, Wfrom 88 ± 5.8 to 44 ± 3.7 mmHg; WKY6Wk, from 107 ± 4.3 to 48 ± 5.6 mmHg; WKYz3Wk, from 120 ± 7.0 to 52 ± 3.8 mmHg) (n = 4) and a concomitant gradual increase in plasma NE concentration (SH4k, Wfrom 1.12 ± 0.20 to 9.84 ± 1.32 pmol/ml; SH6Wk, from 0.74 ± 0.13 to 5.57 ± 0.62 pmol/ml; SH23wk, from 0.28 ± 0.03 to 1.36 ± 0.23 pmol/ml; WKY4Wk, from 0.38 ± 0.12 to 1.26 ± 0.18 pmol/ml; WKY6wk, from 0.36 ± 0.09 to 1.70 ± 0.31 pmol/ml; WKY23wk, from 0.27 ± 0.05 to 2.16 ± 0.48 pmol/ml). An increase in plasma E concentration was also associated with the decrease in blood pressure (SH4Wk, from 0.32 ± 0.12 to 9.79 ± 0.88 pmol/ml; SH6Wk, from 0.25 ± 0.07 to 5.58 ± 0.49 pmol/ml; SH23wk, from 0.12 ± 0.02 to 0.91 ± 0.07 pmol/ml; WKY4Wk, from 0.15 ± 0.03 to 1.08 ± 0.30 pmol/ml; WKY6Wk, from 0.18 ± 0.04 to 1.86 ± 0.56 pmollml; WKY23wk, from 0.08 ± 0.007 to 1.23 ± 0.41 pmol/ml). As shown in Figs. 1 and 2 , the decrease in mean arterial blood pressure correlated with the increase in the plasma NE or E concentration in both SH and WKY rats of the three age groups examined (4, 6, and 23 wk). The relations among these variables were expressed as Y= -aLOG(X) + m , where Y is the mean arterial blood pressure; X, the concentration of plasma NE or E; a, the slope; m, the intercept. As summarized in Tables 1 and 2 , a strong correlation was observed between the decrease in blood pressure and the increase in plasma NE or E concentration.
The slopes (as) for NE or E increased significantly with age in SH rats [NE, SH23wk (176.9 ) > SH6wk (106.4) > SH4wk (73.5) (p<0.01); E, SH23wk (131.7) > SH6wk (67.9) > SH4wk (43.7) (p < 0.01)], but did not change significantly with the age in WKY rats [NE, WKY23wk (77.5), WKY6wk (87.2) and WKY4wk (78.4); E, WKY23wk (58.1), WKY6wk (58.3), and WKY4wk (54.8)]. A greater slope indicates a lower baroreflex sensitivity since it represents a smaller evoked rise in plasma CAs to counter the same reduction in blood pressure (12, 13).
Discussion
Selection of Nicardipine Although nitroprusside or phenylephrine has been used to evaluate sympathetic nervous activity, in this study we used nicardipine, because we have already demonstrated for several calcium antagonists, including nicardipine, the existence of a significant correlation between the decrease in blood pressure and the increases in plasma NE and E concentrations in adult SD (12), SH, and WKY rats (23-wk-old) (13). Nicardipine was also used because it is one of the most widely used dihydropyridine type calcium antagonists clinically.
Selection o f the Anesthetic Agent
We anesthetized the animals with sodium thiobutabarbital. In our previous work (13), we studied the influence of several anesthetic agents on heart rate, blood pressure, and plasma NE and E concentrations in adult WKY and SH rats . We concluded that sodium thiobutabarbital was the anesthetic of choice because it did not affect normal blood pressure or heart rate in the rats and because it provided stable baseline blood pressure and heart rate for at least 2 h, enough time to carry out this type of experiment.
Heart Rate We previously reported a slight increase in heart rate associated with infusion of nicardipine in SD rats anesthetized with sodium pentobarbital (12), which might contribute to maintaining the blood pressure and thereby attenuate the baroreflex-mediated sympathetic activity. However, in the present as well as in a previous study (13), infusion of nicardipine in SH and WKY rats under thiobutabarbital anesthesia was associated with no increase in heart rate in individual rats of either strain. The absence of increments in heart rate permits a more precise assessment of the inherent sensitivity of the baroreflex arc mediating sympathetic activity through blood vessels, except for those in the heart. The combined influence of artificial ventilation and thiobutabarbital anesthesia seem to have stabilized heart rate.
Basal Plasma Levels o f CAs in SH and WKY Rats
We observed that plasma NE and E concentrations were two to three times higher in 4-wk-old and 6-wk-old SH rats than in age-matched WKY rats. In contrast, we observed similar basal plasma NE and E concentrations in adult (23 wk old) rats of both strains. These results agree with the generally accepted notion that CA concentrations are higher in SH rats than in WKY rats only before the onset or during the early phases of hypertension (0-6 wk), whereas in the established phase of hypertension CA concentrations are similar or slightly lower in adult SH rats than in age-matched WKY rats (6-10, 13, 22).
Plasma NE Levels and Blood Pressure after Infusion o f Nicardipine
The strong correlation between the decrease in blood pressure and the increase in plasma NE concentration in both rat strains at all ages examined (4, 6, and 23 wk) (Fig. 1) shows that the baroreflexmediated sympathetic response remains sensitive through the 23 first wk of age.
Plasma E Levels and Blood Pressure after Infusion o f Nicardipine Some reports (4, 6) have suggested that plasma E levels do not markedly increase under normal physiological conditions to compensate for a decrease in blood pressure, and that the role of plasma E in the control of blood pressure is negligible. On the contrary, our present data on increased plasma E concentration in response to blood pressure reduction (Fig. 2) show that in both SH and WKY rats of 4, 6, and 23 wk of age the sympathetic nervous system also stimulates the adrenomedullary secretion of E to help maintain the blood pressure at normal levels, as we reported previously for adult , and SH and WKY rats (13).
Evolution o f Barore f lex Function with Age in SH and WKY Rats A comparison between age-matched SH and WKY rats (Tables 1 and 2) showed that the slopes (a values) of the curves of blood pressure vs. the logarithm of plasma NE in prehypertensive SH4wk (73.5) and normotensive WKY4wk (78.4) rats were not significantly different (p < 0.01; p < 0.05), while the slope for E was significantly smaller in SH4wk (43.7) than in WKY4wk rats (54.8) (p < 0.01). These data indicate that there is no difference in the baroreflex mediated release of NE between 4-wkold SH rats and age-matched WKY rats, whereas there is greater stimulation of E release from the adrenal glands in SH rats. This apparent difference in sympathetic nervous system activity was restricted to 4-wk-old prehypertensive SH rats. In contrast, the slopes for both NE and E were significant- A number of studies have assessed the influence of age and hypertension on the baroceptor reflex. In most, sympathetic nerve activity was evaluated on the basis of the strength of impulses in postganglionic neurons. In the present and previous studies of 4-, 6-and 23-wk old-SH rats (13), we measured plasma catecholamines released from nerve endings as an index of baroreflex-mediated sympathetic activity. Our data indicate that in SH rats there is a gradual reduction in baroreflex-mediated sympathetic activity, evident at 6 wk of age concomitant with the onset of hypertension and associated with the increase in blood pressure with the age, i. e. , with the development and establishment of hypertension. In normotensive WKY rats, inherent baroreflexmediated sympathetic activity is apparently unaltered at least through the 23 first wk of age. Our data agree with the previous findings obtained by neurography (17) , indicating that the baroceptor sensitivity (expressed by mean arterial blood pressure) to the sympathetic nerve activity (expressed by mean renal activity) in SH rats of different ages (12 to 52 wk old) decreases with age, while the sympathetic nerve activity increases with age. Similar results were also recently obtained neurographically in SH rats (10, 28, and 36 wk old) (23) . These studies demonstrate that plasma catecholamines can be used to evaluate changes in baroreflex-mediated sympathetic activity in response to the blood pressure reduction caused by calcium antagonists, although further investigations of other agents, such as nitroprusside, should be done to provide more information on this issue.
Available data do not allow us to determine whether the attenuation of baroreflex activity in SH rats is genetically controlled or whether such attenuation after the development of hypertension in SH rats results from a biological homeostatic mechanism attempting to counter the rise in blood pressure. To clarify this issue, further studies of newborn SH rats given nicardipine throughout their life are necessary. If weakening of baroreflex sensitivity is genetically determined, it would occur even when the development of hypertension is prevented by the administration of nicardipine to newborn SH rats. If attenuation of baroreflex sensitivity is caused by continuous adaptation to the development of hypertension, SH rats would have similar sympathetic activity as normotensive WKY rats for the duration of their life. The early start of treatment with antihypertensive agents such as trichloromethiazide, atenolol, nicardipine, and enalapril in SH rats (10 wk old) has been shown to improve baroceptormediated reflex function at 36 wk of age (23) . Moreover, further studies assessing the response to the discontinuance of treatment are required.
